Search research articles
Contact Us
Filters
Showing results (21-30 of 107) with videos related to
Page
of 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2010
Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic model
Peter Kletting, Thomas Kull, Donald Bunjes, et al.
Diagnostic Microbiology and Infectious Disease
|
July 7, 2020
First case of fatal Rhizomucor miehei endocarditis in an immunocompromised patient
Jürgen Benjamin Hagemann, Martina Furitsch, Verena Wais, et al.
Transplantation
|
June 5, 2003
Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation
Markus Ditschkowski, Hermann Einsele, Rainer Schwerdtfeger, et al.
Haematologica
|
February 8, 2006
Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study
Thorsten Zenz, Gerhard Glatting, Richard F Schlenk, et al.
International Journal of Oncology
|
October 4, 2007
Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner
Jinfei Chen, Anita Schmitt, Krzysztof Giannopoulos, et al.
Acta Haematologica
|
July 12, 2018
Leptomeningeal Myelomatosis: A Rare but Devastating Manifestation of Multiple Myeloma Diagnosed Using Cytology, Flow Cytometry, and Fluorescent in situ Hybridization
Martin Bommer, Miriam Kull, Veronica Teleanu, et al.
Cancers
|
April 30, 2021
Sarcopenia Screening Allows Identifying High-Risk Patients for Allogenic Stem Cell Transplantation
Johannes Kirsten, Verena Wais, Sebastian V W Schulz, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2003
A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy
Inga Buchmann, Thomas Kull, Gerhard Glatting, et al.
Molecular Cancer
|
February 2, 2010
Effects of nilotinib on regulatory T cells: the dose matters
Fei Fei, Yingzhe Yu, Anita Schmitt, et al.
British Journal of Haematology
|
November 20, 2008
Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells
Fei Fei, Yingzhe Yu, Anita Schmitt, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 107) with videos related to
Sort By:
Page
of 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 13, 2010
Radioimmunotherapy with anti-CD66 antibody: improving the biodistribution using a physiologically based pharmacokinetic model
Peter Kletting, Thomas Kull, Donald Bunjes, et al.
Diagnostic Microbiology and Infectious Disease
|
July 7, 2020
First case of fatal Rhizomucor miehei endocarditis in an immunocompromised patient
Jürgen Benjamin Hagemann, Martina Furitsch, Verena Wais, et al.
Transplantation
|
June 5, 2003
Improvement of inflammatory bowel disease after allogeneic stem-cell transplantation
Markus Ditschkowski, Hermann Einsele, Rainer Schwerdtfeger, et al.
Haematologica
|
February 8, 2006
Targeted marrow irradiation with radioactively labeled anti-CD66 monoclonal antibody prior to allogeneic stem cell transplantation for patients with leukemia: results of a phase I-II study
Thorsten Zenz, Gerhard Glatting, Richard F Schlenk, et al.
International Journal of Oncology
|
October 4, 2007
Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner
Jinfei Chen, Anita Schmitt, Krzysztof Giannopoulos, et al.
Acta Haematologica
|
July 12, 2018
Leptomeningeal Myelomatosis: A Rare but Devastating Manifestation of Multiple Myeloma Diagnosed Using Cytology, Flow Cytometry, and Fluorescent in situ Hybridization
Martin Bommer, Miriam Kull, Veronica Teleanu, et al.
Cancers
|
April 30, 2021
Sarcopenia Screening Allows Identifying High-Risk Patients for Allogenic Stem Cell Transplantation
Johannes Kirsten, Verena Wais, Sebastian V W Schulz, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2003
A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy
Inga Buchmann, Thomas Kull, Gerhard Glatting, et al.
Molecular Cancer
|
February 2, 2010
Effects of nilotinib on regulatory T cells: the dose matters
Fei Fei, Yingzhe Yu, Anita Schmitt, et al.
British Journal of Haematology
|
November 20, 2008
Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells
Fei Fei, Yingzhe Yu, Anita Schmitt, et al.
Page
of 11